• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19: a short message to rheumatologists.

作者信息

Leszczyński Piotr

机构信息

Department of Rheumatology and Rehabilitation, Poznań University of Medical Sciences, Poland.

Department of Rheumatology and Osteoporosis, Józef Struś Memorial Multidisciplinary Municipal Hospital in Poznań, Poland.

出版信息

Reumatologia. 2020;58(3):130-133. doi: 10.5114/reum.2020.96685. Epub 2020 Jun 29.

DOI:10.5114/reum.2020.96685
PMID:32684644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7362267/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc9/7362267/182e7e586b23/RU-58-96685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc9/7362267/da85a8de2dcb/RU-58-96685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc9/7362267/182e7e586b23/RU-58-96685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc9/7362267/da85a8de2dcb/RU-58-96685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bc9/7362267/182e7e586b23/RU-58-96685-g002.jpg

相似文献

1
COVID-19: a short message to rheumatologists.新型冠状病毒肺炎：致风湿病学家的一则短讯。
Reumatologia. 2020;58(3):130-133. doi: 10.5114/reum.2020.96685. Epub 2020 Jun 29.
2
Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.关于“风湿性和肌肉骨骼疾病患者对SARS-CoV-2疫苗的犹豫态度：给风湿病学家的启示”的通信
Ann Rheum Dis. 2021 Oct;80(10):e168. doi: 10.1136/annrheumdis-2021-220586. Epub 2021 May 7.
3
Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli .对Smerilli所著《关于“风湿性和肌肉骨骼疾病患者对SARS-CoV-2疫苗的犹豫态度：给风湿病学家的信息”的通信》的回复
Ann Rheum Dis. 2021 Oct;80(10):e169. doi: 10.1136/annrheumdis-2021-220612. Epub 2021 May 7.
4
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.COVID-19 与儿科风湿病医生须知：来自高流行国家的综述
Pediatr Rheumatol Online J. 2020 Apr 22;18(1):35. doi: 10.1186/s12969-020-00422-z.
5
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey.COVID-19 时代的数字风湿病学：一项全国患者和医生调查结果。
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2020-001548.
6
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey.COVID-19 对风湿性疾病脆弱患者的影响：一项全球调查结果。
RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001378.
7
A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany.一项评估德国风湿病学家对 COVID-19 疫苗的知识、看法和态度的调查。
Rheumatol Int. 2021 Nov;41(11):1949-1956. doi: 10.1007/s00296-021-04986-1. Epub 2021 Sep 8.
8
Rheumatologists' knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey.风湿科医生对 COVID-19 及相关疫苗的知识和认知：vaXurvey2 在线调查。
Rheumatol Int. 2022 Jun;42(6):989-998. doi: 10.1007/s00296-022-05130-3. Epub 2022 Apr 16.
9
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists.COVID-19 认知和患者管理的地域差异：风湿病学家的全国性调查。
Semin Arthritis Rheum. 2020 Oct;50(5):1049-1054. doi: 10.1016/j.semarthrit.2020.06.017. Epub 2020 Jul 6.
10
The impact of COVID-19 on rheumatology practice across Africa.COVID-19 对非洲风湿病学实践的影响。
Rheumatology (Oxford). 2021 Jan 5;60(1):392-398. doi: 10.1093/rheumatology/keaa600.

引用本文的文献

1
Identification of Clinical Response Predictors of Tocilizumab Treatment in Patients with Severe COVID-19 Based on Single-Center Experience.基于单中心经验的重症新型冠状病毒肺炎患者托珠单抗治疗临床反应预测指标的识别
J Clin Med. 2023 Mar 22;12(6):2429. doi: 10.3390/jcm12062429.
2
COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity.青少年特发性关节炎患者中的新型冠状病毒肺炎：发病率与严重程度
Reumatologia. 2021;59(3):197-199. doi: 10.5114/reum.2021.107590. Epub 2021 Jul 11.
3
A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children - literature review based on two case reports.

本文引用的文献

1
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
2
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
3
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
儿童巨噬细胞活化综合征与多系统炎症综合征之间的细微差别——基于两例病例报告的文献综述
Reumatologia. 2021;59(1):47-57. doi: 10.5114/reum.2021.102871. Epub 2021 Feb 28.
免疫介导性炎症疾病中的新冠病毒病——来自纽约的病例系列
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
4
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.一系列接受免疫抑制靶向治疗的慢性关节炎患者的 COVID-19 临床病程。
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
5
COVID-19: the new challenge for rheumatologists.新型冠状病毒肺炎：风湿病学家面临的新挑战。
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.
6
Insights from nanomedicine into chloroquine efficacy against COVID-19.纳米医学对氯喹治疗 COVID-19 疗效的启示。
Nat Nanotechnol. 2020 Apr;15(4):247-249. doi: 10.1038/s41565-020-0674-9.
7
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
8
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.巴瑞替尼作为2019新型冠状病毒急性呼吸道疾病的潜在治疗方法。
Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4.
9
Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature.阿那白滞素治疗巨噬细胞活化综合征：单中心经验和文献系统评价。
Clin Rheumatol. 2018 Dec;37(12):3329-3335. doi: 10.1007/s10067-018-4095-1. Epub 2018 Apr 16.
10
A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.一种氯喹诱导的巨噬细胞预处理策略，用于改善纳米递药。
Sci Rep. 2017 Oct 23;7(1):13738. doi: 10.1038/s41598-017-14221-2.